Skip to main content
SpringerLink
Log in

Ointments and transdermal nitroglycerin patches for stable angina pectoris

  • Nitrates
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Nitroglycerin (NTG) ointment is used for the prophylaxis against angina pectoris, but there are no data to support its effectiveness during long-term therapy. Continuous, once-daily application of isosorbide dinitrate cream produces tolerance with complete loss of efficacy within 1 week. Nitroglycerin patches are very popular and continuous once-daily application is still claimed by some investigators to provide 24 hour antiischemic and antianginal efficacy. This claim is based on data from postmarketing studies in a very large number of patients and placebo-controlled studies in smaller groups of patients from Italy, Yugoslavia, Greece, and Germany. In contrast, studies from the United States, Canada, England, and some centers in Germany have failed to show superiority of patches over placebo during continuous therapy. This controversy was addressed by the NTG cooperative study group, in which a total of 562 patients who were responders to sublingual nitroglycerin were studied. Patients received either placebo or NTG patches delivering low (15–30 mg/24 hr), moderate (45–60 mg/ 24 hr), or large (75 and 105 mg/24 hr) amounts of NTG. Four hours after the initial application, NTG patches increased exercise duration compared to placebo, but this beneficial effect had disappeared by 24 hours. Furthermore, after 8 weeks of continuous therapy, none of the NTG patches were superior to placebo, whether patients were or were not taking concomitant beta-blockers. Therefore, current opinion is that continous therapy with NTG patches produces pharmacologic tolerance and is ineffective. Pharmacologic tolerance can be minimized when patches are applied every morning and removed after 10–12 hours at night. However, patches delivering >15 mg NTG/24 hr are required to maintain an increased exercise duration for up to hour 8 after the patch application. Intermittent therapy with patches, however, may lead to rebound nocturnal angina in some patients. Also, intermittent therapy with patches has been associated with worsening of exercise performance in the morning prior to the patch renewal, compared to therapy with placebo patches. This has been referred to as the zero-hour effect and probably represents a rebound phenomenon following nitrate withdrawal. Patients experiencing either nocturnal or early morning angina during intermittent therapy with patches should either be switched to oral long-acting nitrates or should in addition be treated with a beta-blocker, provided there are no contraindications to beta-blocker treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Davis JA, Wiesel BH. The treatment of angina pectoris with a nitroglycerin ointment.Am J Med Sci 1995;230:259–263.

    Google Scholar 

  2. Demma FJ, Wilson RR. The transdermal administration of nitrates: An overview.Angiology 1983;34:1–10.

    PubMed  Google Scholar 

  3. Bogaert MG. Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.Clin Pharmacokin 1987;12:1–11.

    Google Scholar 

  4. Needleman P, Lang S, Johnson EM Jr. Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy.J Pharmacol Exp Ther 1972;181:485–497.

    Google Scholar 

  5. Reichek N, Goldstein RE, Redwood DR, et al. Sustained effects of nitroglycerin ointment in patients with angina pectoris.Circulation 1974;50:348–352.

    PubMed  Google Scholar 

  6. Davidov ME, Mroczek WJ. The effect of nitroglycerin ointment on exercise capacity in patients with angina pectoris.Angiology 1976;27:205–211.

    PubMed  Google Scholar 

  7. Karsh DL, Umbach RE, Cohen LS, et al. Prolonged benefit of nitroglycerin ointment on exercise tolerance in patients with angina pectoris.Am Heart J 1978;96:588–595.

    Google Scholar 

  8. Awan NA, Miller RR, Maxswell KS, et al. Cardiocirculatory and antianginal actions of nitroglycerin ointment.Chest 1978;73:14–18.

    PubMed  Google Scholar 

  9. Davidov ME. Cutaneous administration of nitroglycerin in patients with angina pectoris.Angiology 1981;32:16–20.

    PubMed  Google Scholar 

  10. Hubner PJB, Jones PRM, Galer IAR. Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris.Br Med J 1985;290:514–516.

    Google Scholar 

  11. Armstrong PW, Armstrong JA, Marks GS. Pharmacokinetics hemodynamic studies of nitroglycerin ointment in congestive heart failure.Am J Cardiol 1980;48:670–675.

    Google Scholar 

  12. Müller P, Imhof PR, Burkart F, et al. Human pharmacological studies of a new transdermal system containing nitroglycerin.Eur J Clin Pharmacol 1982;22:473–480.

    PubMed  Google Scholar 

  13. Chien YW. Pharmaceutical considerations of transdermal nitroglycerin delivery: The various approaches.Am Heart J 1984;108:207–216.

    PubMed  Google Scholar 

  14. Thompson RH. The clinical use of transdermal delivery devices with nitroglycerin.J Vasc Dis 1983:23–31.

  15. Georgopoulos AJ, Markis A, Georgiadis H. Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris.Eur J Clin Pharmacol 1982;22:481–485.

    PubMed  Google Scholar 

  16. Letzel H, Johnson LC. Advances in nitrate therapy for ischemic heart disease: Results of a multicenter study with nitroderm TTS.Selecta 1983;16(Suppl):13–14.

    Google Scholar 

  17. Bridman KM, Carr M, Tattersall AB. Post-marketing surveillance of the transiderm-nitro patch in general practice.J Int Med Res 1984;12:40–45.

    PubMed  Google Scholar 

  18. Crean PA, Ribeiro P, Crea F, et al. Failure of transdermal nitroglycerin to improve chronic stable angina: A randomized placebo-controlled, double-blind, double crossover trial.Am Heart J 1984;108:1494–1500.

    PubMed  Google Scholar 

  19. Parker JO, Fung HL. Transdermal nitroglycerin in angina pectoris.Am J Cardiol 1984;54:471–476.

    PubMed  Google Scholar 

  20. Reichek N, Priest C, Zimrin D, et al. Antianginal effects of nitroglycerin patches.Am J Cardiol 1984;54:1–7.

    PubMed  Google Scholar 

  21. Sullivan M, Savvides M, Abouantoun S, et al. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.J Am Coll Cardiol 1985;5:1220–1223.

    PubMed  Google Scholar 

  22. James MA, Walker PR, Papouchado M, et al. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.Br Heart J 1985;53:631–635.

    PubMed  Google Scholar 

  23. Reiniger G, Rudolph W. Therapie der koronaren herzerkrankung mit nitroglycerinflastern.Herz 1985;10:305–311.

    PubMed  Google Scholar 

  24. Thadani U, Hamilton SF, Olson E, et al. Transdermal nitroglycerin patches in angina pectoris.Ann Intern Med 1986;105:485–492.

    PubMed  Google Scholar 

  25. Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: A randomized controlled trial of transdermal glyceryl trinitrate against placebo.Lancet 1988;ii:4–8.

    Google Scholar 

  26. Metelitsa VI, Martsevich SY, Piotrovskii VK. New transdermal and transmucosal nitroglycerin delivery systems in patients with ischemic heart disease.Eur J Clin Pharmacol 1987;32:5–10.

    PubMed  Google Scholar 

  27. Karlson BW, Henning R. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: A double-blind controlled study.Clin Cardiol 1987;10:573–577.

    PubMed  Google Scholar 

  28. Frishman WF, Giles T, Greenberg S, et al. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: Evidence for attenuation of effect over time.J Clin Pharmacol 1989;29:1097–1105.

    PubMed  Google Scholar 

  29. Bassan MM, Rogel S. A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: A double-blind study using dose titration.Eur Heart J 1992;13:1265–1270.

    PubMed  Google Scholar 

  30. Reifart N, Bussman WD. Placebo-kontrollierte doppelblind-studie zur antiischëmischen wirksamkeit und wirkdauer von transdermalem depotnitrat.Z Kardiol 1986;75(Suppl 3):83–85.

    Google Scholar 

  31. Thadani U, Fung HL, Darke AC, et al. Oral isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose response relation during acute and sustained therapy.Am J Cardiol 1982;49:411–419.

    PubMed  Google Scholar 

  32. Cerri B, Grasso F, Cefis M, et al. Comparative evaluation of the effect of two doses of nitroderm TTS on exercise-related parameters in patients with angina pectoris.Eur Heart J 1984;5:710–715.

    PubMed  Google Scholar 

  33. Naafs MA, De Boer AC, Koster RW, et al. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.Eur Heart J 1984;5:705–709.

    PubMed  Google Scholar 

  34. Schneider W, Michel O, Kaltenbach M, et al. The antianginal effect of transdermally-applied nitroglycerin as a function of the patch size.Dtsch Med Wochenschr 1985;110:87–91.

    PubMed  Google Scholar 

  35. Sellier P, Audouin P, Payen B, et al. Therapeutic efficacy of transcutaneously absorbed nitroglycerin evaluated by exercise testing in angina pectoris.Cardiovasc Rev Rep 1985;6:80–88.

    Google Scholar 

  36. Hollenberg M, Go M. Clinical studies with transdermal nitroglycerin.Am Heart J 1984;108:223–231.

    PubMed  Google Scholar 

  37. Martines C. Comparison of the prophylactic antianginal effect of two doses of nitroderm TTS in out-patients with stable angina pectoris. Comparison of the prophylactic antianginal effect of two doses of nitroderm TTS in outpatient with stable angina pectoris.Curr Ther Res 1984;36:483–489.

    Google Scholar 

  38. Rezaković DE, Pavičić L, Majačić M. A randomized placebo controlled, double-blind crossover trial of transdermal nitroglycerin in stable angina pectoris.Eur Heart J 1988;9(Suppl A):73–81.

    Google Scholar 

  39. Imhof PR, Müller P, Garnier B. Nitroderm TTS versus oral isosorbide dinitrate: A double-blind trial in patients with angina pectoris.Acta Therapeutica 1985;11:155–168.

    Google Scholar 

  40. Scardi S, Pivotti F, Fonda F, et al. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.Am Heart J 1985;110:547–551.

    Google Scholar 

  41. Thompson R. Influence of transdermal nitrates on exercise capacity in patients with stable angina.J Vasc Dis 1986;38:448–453.

    Google Scholar 

  42. Pucci P, Zambaldi G, Cerisano G, et al. Evaluation of a new preparation of transdermal nitroglycerin for patients with angina of effort.G Ital Cardiol 1983;13:167–171.

    PubMed  Google Scholar 

  43. Shell WE, Dobson D. Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris.Am J Cardiol 1990;66:42–48.

    PubMed  Google Scholar 

  44. Muiesan G, Agabiti-Rosei E, Muisan L. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: Individual antianginal response after repeated administration.Am Heart J 1986;112:233–238.

    PubMed  Google Scholar 

  45. Gibelli G, Negrini M, Bruno AM, et al. Chronic effects of transdermal nitroglycerin in stable angina pectoris: A within patient, placebo controlled study.Int J Clin Pharmacol Ther Toxicol 1989;27:436–441.

    PubMed  Google Scholar 

  46. Greco R, DéAlterio D, Schiattarella M. Efficacy of a new transdermal nitroglycerin patch (Depoint 10) for stable angina pectoris.Am J Cardiol 1988;61:44E-51E.

    PubMed  Google Scholar 

  47. Caru B, Pirelli S, Ferrantini M, et al. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerin, in patients with stable angina pectoris.Eur Heart J 1988;9(Suppl A):105–111.

    Google Scholar 

  48. Rezaković DE, Pavičić L, Majačić M. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.Eur Heart J 1988;9(Suppl A):73–81.

    Google Scholar 

  49. Greco R, Schiattarella M, Wolff S, et al. Long-term efficacy of nitroglycerin patch in stable angina pectoris.Am J Cardiol 1990;65:9J-15J.

    PubMed  Google Scholar 

  50. Bassan M. The day-long antianginal effectiveness of nitroglycerin patches.Chest 1991;99:1120–1125.

    PubMed  Google Scholar 

  51. Scardi S, Camareni F, Pandullo G, et al. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort induced angina pectoris: A multicenter study.Int J Cardiol 1991;32:241–248.

    PubMed  Google Scholar 

  52. Steering Committee, Transdermal Nitroglycerin Cooperative study. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin.Am J Cardiol 1991;68:1263–1273.

    Google Scholar 

  53. Klemsdal TO, Gjesdal K. The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time—a meta-analysis.Cardiovasc Drugs Ther 1992;6:641–649.

    PubMed  Google Scholar 

  54. Bennett D, Daviesa A, Davis A. Sustained anti-anginal action of glyceryl trinitrate cream.Br J Clin Pharmacol 1983;15:173–180.

    PubMed  Google Scholar 

  55. Parker JO, Van Koughnett KA, Fung HL. Transdermal isosorbide dinitrate in angina pectoris.Am J Cardiol 1984;54:8–13.

    PubMed  Google Scholar 

  56. Handler CI, Sullivan ID. Double-blind randomized crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.Int J Cardiol 1985;7:149–156.

    PubMed  Google Scholar 

  57. Thadani U. The effectiveness of transcutaneous nitrate preparations for angina pectoris.Int J Cardiol 1987;14:9–14.

    PubMed  Google Scholar 

  58. Abrams J. The brief saga of transdermal nitroglycerin discs: Paradise lost?Am J Cardiol 1984;64:220–224.

    Google Scholar 

  59. Colditz GA, Halvorsen KT, Goldhaber SZ. Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: A meta analysis.Am Heart J 1988;116:174–180.

    PubMed  Google Scholar 

  60. Abrams J. Transcutaneous nitroglycerin—ointment or disc?Am Heart J 1984;108:1597–1600.

    PubMed  Google Scholar 

  61. Bogaert MA, Deschaepdryver AF. Tolerance towards glyceryl trinitrate (trinitrin) in dogs.Arch Int Pharmacodyn Ther 1968;171:221–224.

    PubMed  Google Scholar 

  62. Needleman P. Tolerance to the vascular effects of glyceryl trinitrin.J Pharmacol Exp Ther 1970;171:98–102.

    PubMed  Google Scholar 

  63. Needleman P, Johnson EM Jr. Mechanism of tolerance to organic nitrates.J Pharmacol Exp Ther 1973;184:709–715.

    PubMed  Google Scholar 

  64. Bassange E. Nitrates in different vascular beds: Nitrate tolerance and interaction with endothelial function.Am J Cardiol 1992;70:23B-29B.

    PubMed  Google Scholar 

  65. Fung HL, Chong S, Kowaulk E, et al. Mechanism for pharmacologic interaction of nitrates with thiols: Existence of an extracellular pathway for the reversal of nitrates by n-acetylcysteine.J Pharmacol Exp Ther 1988:524–530.

  66. Schwartz AM. The cause, relief and prevention of headaches arising from contact with dynamite.N Engl J Med 1946;235:651.

    Google Scholar 

  67. Morton WE. Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension.J Occup Med 1977;19:197–199.

    PubMed  Google Scholar 

  68. Klock JC. Nonocclusive coronary disease after chronic exposure to nitrates for physiologic nitrate dependence.Am Heart J 1975;89:510.

    PubMed  Google Scholar 

  69. Thadani U, Whitsett T. Relationship of pharmacokinetics and pharmacodynamic properties of organic nitrates.Clin Pharmacokinet 1988;15:32–43.

    PubMed  Google Scholar 

  70. Thadani U, Whitsett T, Hamilton SF. Nitrate therapy for myocardial ischemic syndrome: Current perspectives including tolerance.Curr Probl Cardiol 1988;13:725–784.

    Google Scholar 

  71. Gjesdal K, Klemsdal TO, Rykke EO, et al. Transdermal nitrate therapy: Bioavailability during exercise increases transiently after the daily change of patch.Br J Clin Pharmacol (1991);31:560–562.

    PubMed  Google Scholar 

  72. Zimrin D, Reichek N, Bogin K, et al. Antianginal effects of intravenous nitroglycerin over 24 hours.Circulation 1988;77:1376–1384.

    PubMed  Google Scholar 

  73. Cowan JC, Bourke JP, Reid DS. Prevention of tolerance to nitroglycerin patches by overnight removal.Am J Cardiol 1987;60:271–275.

    PubMed  Google Scholar 

  74. Luke R, Sharpe N, Coxon R. Transdermal nitroglycerin in angina pectoris: Efficacy of intermittent application.J Am Coll Cardiol 1987;10:642–646.

    PubMed  Google Scholar 

  75. Nabel EG, Barry J, Rocco MB, et al. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.Am J Cardiol 1989;63:664–665.

    Google Scholar 

  76. Waters DD, Juneau M, Gossard D, et al. Limited usefulness of intermittent nitroglycerin patches in stable angina.J Am Coll Cardiol 1989;13:421–425.

    PubMed  Google Scholar 

  77. de Milliano PA, Koster RW, Bar FW. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.Am J Cardiol 1991;68:857–862.

    PubMed  Google Scholar 

  78. James MA, Papouchado M, Jones JV. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance.Eur Heart J 1991;12:1266–1272.

    PubMed  Google Scholar 

  79. Knuuti MJ, Wahl M, Wiklund I, et al. Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina.Am J Cardiol 1992;69:1525–1532.

    PubMed  Google Scholar 

  80. Scardi S, Camerini F, Pandullo C, et al. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: A multicenter study.Int J Cardiol 191;32:241–248.

  81. Schaer DH, Buff LA, Katz RJ. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate free interval.Am J Cardiol 1988;61:46–50.

    PubMed  Google Scholar 

  82. DeMots H, Glasser SP and the Transderm-Nitro Study Group. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.J Am Cardiol 1989;13:786–793.

    Google Scholar 

  83. Fox KM, Dargie HJ, Deanfield J, et al. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate.Br Heart J 1991;66:151–155.

    PubMed  Google Scholar 

  84. Rossett E, Luca C, Bonetti F, et al. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.J Am Coll Cardiol 1993;21:337–342.

    PubMed  Google Scholar 

  85. Holdright DR, Katz RJ, Wright CA, et al. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background β blocker.Br Heart J 1993;69:223–227.

    PubMed  Google Scholar 

  86. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischemic burden and its alteration with antianginal agents.Lancet 1989;2:755–758.

    PubMed  Google Scholar 

  87. Thadani U. Medical therapy of stable angina pectoris.Cardiol Clin 1991;9:73–85.

    PubMed  Google Scholar 

  88. Thadani U. Role of nitrates in angina pectoris.Am J Cardiol 1992;70:43B-53B.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

    Udho Thadani MBBS & Raymond J. Lipicky

  2. the Food and Drug Administration, Center for Drug Research and Review, Office of Drug Evaluation I, Division of Cardiorenal Drug Products, Bethesda, Maryland

    Udho Thadani MBBS & Raymond J. Lipicky

Authors
  1. Udho Thadani MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond J. Lipicky
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The opinions expressed here are those of the authors and should not be taken as those of FDA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thadani, U., Lipicky, R.J. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drug Ther 8, 625–633 (1994). https://doi.org/10.1007/BF00877416

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877416

Key Words

Search

Navigation